phenobarbital has been researched along with methyldopa in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 22 (59.46) | 18.7374 |
1990's | 1 (2.70) | 18.2507 |
2000's | 8 (21.62) | 29.6817 |
2010's | 6 (16.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Daniell, HB; Ducker, TB; Salcman, M | 1 |
Sjoerdsma, A | 1 |
Fekete, S; Földvári, A; Gachályi, B; Káldor, A; Kállay, K | 2 |
Hirota, Y | 1 |
Abdella, TN; Anderson, GD; Brooks, TF; Sibai, BM; Spinnato, JA; Taslimi, M | 1 |
Fox, GR; Virgo, BB | 1 |
McCoubrie, M; Snaith, RP | 1 |
Dhasmana, KM; Fokker, WA; Spilker, BA | 1 |
Hansen, T; Jorgensen, M; Kristensen, M | 1 |
Gachályi, B; Káldor, A; Kökény, M | 2 |
Gazengel, J; Lhermitte, F; Marteau, R; Peterfalvi, M; Serdaru, M | 1 |
Benjamin, MV; Goodgold, A; Ransohoff, J | 1 |
Demeczky, M; Juvancz, P; Káldor, A; Sebestyén, K | 1 |
Koe, BK; Weissman, A | 1 |
Demeczky, M; Juvancz, P; Káldor, A; Palotas, J; Sebestyen, K | 1 |
Mackie, BS | 1 |
Batson, HM; Birchall, R; Weber, GF | 1 |
Erõs, I; Kása, P; Pintye-Hódi, K; Siaan, M; Szabó-Révész, P | 1 |
Szakács, T; Vereczkey, L; Veres, Z | 1 |
MARSH, DO; MARSHALL, J; SCHNIEDEN, H | 1 |
HANS, SF; KOPELMAN, H | 1 |
MILLIGAN, J; TURNER, RW | 1 |
Barton, D; Loprinzi, CL; Stearns, V | 1 |
1 review(s) available for phenobarbital and methyldopa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for phenobarbital and methyldopa
Article | Year |
---|---|
[The effect of alpha methyldopa and phenobarbital on angiotensin sensitivity and renin activity in man].
Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Clinical Trials as Topic; Drug Interactions; Female; Humans; Male; Methyldopa; Middle Aged; Phenobarbital; Renin | 1975 |
Enhancement of methyldopa metabolism with barbiturate.
Topics: Catecholamines; Enzyme Induction; Epinephrine; Humans; Hypertension; Liver; Methyldopa; Microsomes, Liver; Norepinephrine; Phenobarbital | 1971 |
34 other study(ies) available for phenobarbital and methyldopa
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Experimental spinal cord trauma, III: Therapeutic effect of immobilization and pharmacologic agents.
Topics: Animals; Dextrans; Haplorhini; Immobilization; Methyldopa; Phenobarbital; Phenoxybenzamine; Spinal Cord Injuries; Vasoconstrictor Agents | 1978 |
Central action as a key to past and future therapy of hypertension.
Topics: Atropine; Brain; Humans; Hypertension; Methyldopa; Pargyline; Phenobarbital; Propranolol; Receptors, Adrenergic; Research Design | 1977 |
Effect of alphamethyldopa and of phenobarbitone on angiotensin responsiveness and renin activity in man.
Topics: Adolescent; Adult; Angiotensin II; Blood Pressure; Drug Interactions; Female; Humans; Male; Methyldopa; Middle Aged; Phenobarbital; Renin | 1975 |
[Hemopoietic disorder caused by drugs--special significance placed on anemia].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Anemia, Hemolytic; Anemia, Megaloblastic; Anemia, Sideroblastic; Chloramphenicol; Ethanol; Humans; Methotrexate; Methyldopa; Middle Aged; Neomycin; Penicillins; Phenacetin; Phenobarbital | 1991 |
Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester.
Topics: Administration, Oral; Antihypertensive Agents; Bed Rest; Birth Weight; Delivery, Obstetric; Diuretics; Female; Fetal Death; Gestational Age; Humans; Hydralazine; Infant, Newborn; Magnesium Sulfate; Methyldopa; Outcome and Process Assessment, Health Care; Phenobarbital; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Second; Pregnancy, Prolonged; Retrospective Studies | 1985 |
The effects of phenobarbital, atropine, L-alpha-methyldopa, and DL-propranolol on dieldrin-induced hyperglycemia in the adult rat.
Topics: Administration, Oral; Animals; Atropine; Blood Glucose; Central Nervous System; Dieldrin; Drug Interactions; Gluconeogenesis; Hypoglycemia; Lethal Dose 50; Liver; Male; Methyldopa; Phenobarbital; Phosphoenolpyruvate Carboxykinase (GTP); Propranolol; Rats; Rats, Inbred Strains | 1985 |
Psychiatric side effects of nonpsychiatric drugs.
Topics: Aminophylline; Analgesics; Anti-Anxiety Agents; Anti-Bacterial Agents; Anticonvulsants; Antiemetics; Antihypertensive Agents; Central Nervous System Stimulants; Chlordiazepoxide; Diazepam; Diuretics; Drug-Related Side Effects and Adverse Reactions; Furosemide; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Insulin; Isoniazid; Mental Disorders; Methyldopa; Phenobarbital; Prednisone | 1971 |
Antihypertensive drugs and depression.
Topics: Adult; Aged; Antihypertensive Agents; Bethanidine; Chlorthalidone; Depression; Diuretics; Drug Therapy, Combination; Fatigue; Furosemide; Guanethidine; Humans; Hydrochlorothiazide; Methyldopa; Middle Aged; Phenobarbital; Potassium; Pyrazines; Reserpine; Self-Assessment; Sodium Chloride Symporter Inhibitors; Theobromine | 1974 |
Peripheral cardiovascular effects, in the pithed rat, of compounds used in the treatment of hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Clonidine; Cordotomy; Diazoxide; Electric Stimulation; Ergotamine; Guanethidine; Hydrochlorothiazide; Iproniazid; Male; Mecamylamine; Methyldopa; Pargyline; Phenobarbital; Rats; Reserpine; Sympathetic Nervous System; Thiocyanates; Trimethaphan | 1972 |
Barbiturates and methyldopa metabolism.
Topics: Drug Interactions; Humans; Methyldopa; Phenobarbital | 1973 |
[The effect of alpha methyldopa and barbiturate on the bile secretion].
Topics: Animals; Bile; Drug Synergism; Methyldopa; Phenobarbital; Rats; Secretory Rate | 1973 |
[Pharmacological analysis of a case of postanoxic intention and action myoclonus].
Topics: 5-Hydroxytryptophan; Alcohols; Anticonvulsants; Benzoates; Carbamazepine; Chlorpromazine; Diazepam; Dibenzazepines; Dopamine; Ergotamine; Female; Haloperidol; Humans; Hypoxia, Brain; Methotrimeprazine; Methyldopa; Methysergide; Middle Aged; Myoclonus; Norepinephrine; Phenobarbital; Pyrrolidines; Stereotaxic Techniques; Sulfonamides; Tranquilizing Agents; Trihexyphenidyl | 1971 |
Preoperative management of patients with ruptured intracranial aneurysms.
Topics: Adult; Aged; Aminocaproates; Antifibrinolytic Agents; Antihypertensive Agents; Blood Pressure; Carotid Artery Diseases; Cerebral Angiography; Cerebral Arterial Diseases; Cerebral Hemorrhage; Chlorothiazide; Female; Humans; Intracranial Aneurysm; Ischemic Attack, Transient; Male; Methyldopa; Middle Aged; Phenobarbital; Preoperative Care; Spinal Puncture; Subarachnoid Hemorrhage | 1972 |
Methyldopa metabolism and barbiturates.
Topics: Animals; Barbiturates; Bile; Drug Interactions; Female; Injections, Intraperitoneal; Methyldopa; Phenobarbital; Rats | 1972 |
[Enhancing alphamethyldopa metabolism with barbiturates in man].
Topics: Drug Synergism; Epinephrine; Humans; Methyldopa; Norepinephrine; Phenobarbital | 1971 |
m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Anticonvulsants; Atropine; Azoles; Brain; Chlordiazepoxide; Chlorpromazine; Citrates; Dihydroxyphenylalanine; Disulfiram; Drug Antagonism; Drug Synergism; Kidney; Lysergic Acid Diethylamide; Male; Methyldopa; Mice; Morphine; Nialamide; Norepinephrine; Pargyline; Phenobarbital; Phenytoin; Reserpine; Seizures; Serotonin; Strychnine; Tetrabenazine; Trimethadione; Tyrosine; Urea | 1967 |
Drug-induced ulcer of the lip.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Chlorpromazine; Diagnosis, Differential; Female; Humans; Hydrocortisone; Lip; Male; Methyldopa; Middle Aged; Mouth Diseases; Phenobarbital; Phenylbutazone; Ulcer | 1967 |
Arteriosclerotic hypertension often misdiagnosed, overtreated.
Topics: Arteriosclerosis; Humans; Hypertension; Methyldopa; Phenobarbital; Prognosis; Reserpine | 1967 |
Influence of Avicel PH-301 on the compressibility of alpha-methyldopa and phenobarbitone in direct compression.
Topics: Anticonvulsants; Antihypertensive Agents; Cellulose; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Compressive Strength; Elasticity; Excipients; Friction; Hypnotics and Sedatives; Lubrication; Methyldopa; Phenobarbital; Stearic Acids; Tablets; Technology, Pharmaceutical | 2000 |
Effect of alpha-methyldopa on pentoxyresorufin O-dealkylation in liver microsomes from rats treated with phenobarbital.
Topics: Animals; Ascorbic Acid; Cytochrome P-450 CYP2B1; Cytochrome P-450 CYP2E1 Inhibitors; Dopamine; Enzyme Inhibitors; Glutathione; Levodopa; Lipid Peroxidation; Male; Methyldopa; Microsomes, Liver; NADP; Oxazines; Phenobarbital; Rats; Rats, Wistar | 2001 |
A CONTROLLED CLINICAL TRIAL OF ALPHA METHYL DOPA IN PARKINSONIAN TREMOR.
Topics: Depression; Depressive Disorder; Hypnotics and Sedatives; Methyldopa; Parasympatholytics; Parkinsonian Disorders; Phenobarbital; Placebos; Toxicology; Tremor | 1963 |
METHYLDOPA IN TREATMENT OF SEVERE TOXAEMIA OF PREGNANCY.
Topics: Albuminuria; Antihypertensive Agents; Chlorothiazide; Female; Fetal Death; Humans; Methyldopa; Phenobarbital; Pre-Eclampsia; Pregnancy; Prognosis; Selective Serotonin Reuptake Inhibitors; Serotonin | 1964 |
HYPERTENSION AND ITS COMPLICATIONS. 2.
Topics: Amobarbital; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cold Temperature; Diuretics; Guanethidine; Humans; Hypertension; Kidney Function Tests; Mecamylamine; Methyldopa; Nursing; Obesity; Ophthalmoscopy; Pempidine; Phenobarbital; Physical Exertion; Reserpine; Therapeutics; Toxicology | 1964 |
Centrally active nonhormonal hot flash therapies.
Topics: Amines; Antidepressive Agents; Antihypertensive Agents; Belladonna Alkaloids; Clonidine; Cyclohexanecarboxylic Acids; Drug Combinations; Ergotamines; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; Methyldopa; Methysergide; Phenobarbital | 2005 |